These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 35914366)

  • 41. Infantile-onset spinocerebellar ataxia and mitochondrial recessive ataxia syndrome are associated with neuronal complex I defect and mtDNA depletion.
    Hakonen AH; Goffart S; Marjavaara S; Paetau A; Cooper H; Mattila K; Lampinen M; Sajantila A; Lönnqvist T; Spelbrink JN; Suomalainen A
    Hum Mol Genet; 2008 Dec; 17(23):3822-35. PubMed ID: 18775955
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Metabolic rescue in pluripotent cells from patients with mtDNA disease.
    Ma H; Folmes CD; Wu J; Morey R; Mora-Castilla S; Ocampo A; Ma L; Poulton J; Wang X; Ahmed R; Kang E; Lee Y; Hayama T; Li Y; Van Dyken C; Gutierrez NM; Tippner-Hedges R; Koski A; Mitalipov N; Amato P; Wolf DP; Huang T; Terzic A; Laurent LC; Izpisua Belmonte JC; Mitalipov S
    Nature; 2015 Aug; 524(7564):234-8. PubMed ID: 26176921
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mitochondrial DNA degradation: A quality control measure for mitochondrial genome maintenance and stress response.
    Zhao L
    Enzymes; 2019; 45():311-341. PubMed ID: 31627882
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Autosomal disorders of mitochondrial DNA maintenance.
    Van Goethem G
    Acta Neurol Belg; 2006 Jun; 106(2):66-72. PubMed ID: 16898256
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Modeling mitochondrial DNA diseases: from base editing to pluripotent stem-cell-derived organoids.
    Tolle I; Tiranti V; Prigione A
    EMBO Rep; 2023 Apr; 24(4):e55678. PubMed ID: 36876467
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Significance of Mitochondria DNA Mutations in Diseases.
    Zhu Z; Wang X
    Adv Exp Med Biol; 2017; 1038():219-230. PubMed ID: 29178079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. POLG-related disorders: defects of the nuclear and mitochondrial genome interaction.
    Milone M; Benarroch EE; Wong LJ
    Neurology; 2011 Nov; 77(20):1847-52. PubMed ID: 22084276
    [No Abstract]   [Full Text] [Related]  

  • 49. Genetics of Mitochondrial Disease.
    Saneto RP
    Adv Genet; 2017; 98():63-116. PubMed ID: 28942795
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How Far Can Mitochondrial DNA Drive the Disease?
    Sun H; Shi W; Wang X
    Adv Exp Med Biol; 2017; 1038():1-8. PubMed ID: 29178065
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mitochondrial DNA, mitochondrial dysfunction, and cardiac manifestations.
    Lee SR; Kim N; Noh Y; Xu Z; Ko KS; Rhee BD; Han J
    Front Biosci (Landmark Ed); 2016 Jun; 21(7):1410-26. PubMed ID: 27100514
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mitochondrial DNA maintenance: an appraisal.
    Akhmedov AT; Marín-García J
    Mol Cell Biochem; 2015 Nov; 409(1-2):283-305. PubMed ID: 26286847
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of chemically modified oligonucleotides targeting a pathogenic mutation in human mitochondrial DNA.
    Tonin Y; Heckel AM; Dovydenko I; Meschaninova M; Comte C; Venyaminova A; Pyshnyi D; Tarassov I; Entelis N
    Biochimie; 2014 May; 100():192-9. PubMed ID: 23994754
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mitochondrial DNA: Unraveling the "other" genome.
    Heuer B
    J Am Assoc Nurse Pract; 2021 Sep; 33(9):673-675. PubMed ID: 34491238
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Defects of intergenomic communication: autosomal disorders that cause multiple deletions and depletion of mitochondrial DNA.
    Hirano M; Marti R; Ferreiro-Barros C; Vilà MR; Tadesse S; Nishigaki Y; Nishino I; Vu TH
    Semin Cell Dev Biol; 2001 Dec; 12(6):417-27. PubMed ID: 11735376
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders.
    Palin EJ; Paetau A; Suomalainen A
    Brain; 2013 Aug; 136(Pt 8):2379-92. PubMed ID: 23811324
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mitochondrial dysfunction: mechanisms and advances in therapy.
    Zong Y; Li H; Liao P; Chen L; Pan Y; Zheng Y; Zhang C; Liu D; Zheng M; Gao J
    Signal Transduct Target Ther; 2024 May; 9(1):124. PubMed ID: 38744846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mitochondrial genetic medicine.
    Wallace DC
    Nat Genet; 2018 Dec; 50(12):1642-1649. PubMed ID: 30374071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The use of mitochondria-targeted endonucleases to manipulate mtDNA.
    Bacman SR; Williams SL; Pinto M; Moraes CT
    Methods Enzymol; 2014; 547():373-97. PubMed ID: 25416366
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mitochondrial transcript maturation and its disorders.
    Van Haute L; Pearce SF; Powell CA; D'Souza AR; Nicholls TJ; Minczuk M
    J Inherit Metab Dis; 2015 Jul; 38(4):655-80. PubMed ID: 26016801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.